ClearPoint Neuro (CLPT) Non-Current Deffered Revenue (2018 - 2026)

ClearPoint Neuro has disclosed Non-Current Deffered Revenue across 9 years of filings, most recently posting $608000.0 for Q1 2026.

• Non-Current Deffered Revenue for Q1 2026 came in at $608000.0, up 70.31% year-over-year; the trailing twelve-month figure through Mar 2026 was $608000.0 (up 70.31% YoY), and the FY2025 annual result was $581000.0, up 33.26% from the prior year.
• Non-Current Deffered Revenue came in at $608000.0 for Q1 2026 at ClearPoint Neuro, up from $581000.0 in the prior quarter.
• In the past five years, Non-Current Deffered Revenue ranged from a high of $769000.0 in Q3 2025 to a low of $253000.0 in Q2 2023.
• The 5-year median for Non-Current Deffered Revenue is $446000.0 (2024), against an average of $466235.3.
• Across the five-year window, Non-Current Deffered Revenue tumbled 36.91% in 2023 and surged 76.28% in 2024, its largest moves.
• ClearPoint Neuro's Non-Current Deffered Revenue stood at $390000.0 in 2022, then surged by 38.72% to $541000.0 in 2023, then retreated by 19.41% to $436000.0 in 2024, then soared by 33.26% to $581000.0 in 2025, then climbed by 4.65% to $608000.0 in 2026.
• The last three Non-Current Deffered Revenue figures came in at $608000.0 (Q1 2026), $581000.0 (Q4 2025), and $769000.0 (Q3 2025), per Business Quant data.